Martin Heidecker - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Martin Heidecker’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Hospitals,
- Wellness,
- Women Founded,
- Medical Testing,
- Chemical Engineering,
- Chemical,
- Artificial Intelligence (AI),
- Biotech,
- Software,
- Healthcare,
- Biotechnology,
- Impact Investing,
- Health Diagnostics,
- Beauty,
- Medical,
- Real Estate,
- Therapeutics,
- Advanced Materials,
- Machine Learning,
- Personal Health,
- Pharmaceuticals,
- Clean Energy
Social media:
Past investments:
- Aignostics
- T3 Pharmaceuticals
- Dopavision
- Topas Therapeutics
- Actym
- eTheRNA immunotherapies
- STAT-Dx
- Rinri Therapeutics
- Rigontec
- Hookipa Pharma
- Tacalyx
- NBE-Therapeutics
- Aelin Therapeutics
- Okairos
- ImCheck Therapeutics
- Wellth
- T-knife
- Brainomix
- Acousia Therapeutics
- Rgenta Therapeutics
- DiogenX
- Cardior Pharmaceuticals
- Delonix Bioworks
- Bodyport
- Ruipeng Pet Healthcare
- Metabomed
- ArmaGen Technologies
- Rewind Therapeutics
- HepaRegeniX
- Perfood
- Eyevensys
- Promethera Biosciences
- Sentien Biotechnologies
- Amal Therapeutics
- Vira Therapeutics
- OncoMyx Therapeutics
- Libra Therapeutics
- Abalos Therapeutics
- Venatorx Pharmaceuticals
- AgomAb Therapeutics
Investor Profile
Martin Heidecker is a Corporate Venture Capital, Investor, Venture Capital, Private Equity Firm, Investment Partner based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actym, eTheRNA immunotherapies, STAT-Dx, Rinri Therapeutics, Rigontec, Hookipa Pharma, Tacalyx, NBE-Therapeutics, Aelin Therapeutics, Okairos, ImCheck Therapeutics, Wellth, T-knife, Brainomix, Acousia Therapeutics, Rgenta Therapeutics, DiogenX, Cardior Pharmaceuticals, Delonix Bioworks, Bodyport, Ruipeng Pet Healthcare, Metabomed, ArmaGen Technologies, Rewind Therapeutics, HepaRegeniX, Perfood, Eyevensys, Promethera Biosciences, Sentien Biotechnologies, Amal Therapeutics, Vira Therapeutics, OncoMyx Therapeutics, Libra Therapeutics, Abalos Therapeutics, Venatorx Pharmaceuticals, AgomAb Therapeutics. Over time, Martin Heidecker has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Martin Heidecker is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Women Founded, Medical Testing, Chemical Engineering, Chemical, Artificial Intelligence (AI), Biotech, Software, Healthcare, Biotechnology, Impact Investing, Health Diagnostics, Beauty, Medical, Real Estate, Therapeutics, Advanced Materials, Machine Learning, Personal Health, Pharmaceuticals, Clean Energy may find it worthwhile to explore potential connections with Martin Heidecker, as their portfolio suggests a familiarity and interest in this area.
Understanding Martin Heidecker’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
